共查询到20条相似文献,搜索用时 31 毫秒
1.
Background: The use of sentinel node biopsy (SNB) in breast cancer patients with large and/or multifocal tumours is controversial. Methods: A review of clinical records was undertaken for 213 consecutive patients undergoing SNB for invasive breast cancer from September 2000 to February 2006. The results of SNB and axillary dissection were compared for patients with unifocal or multifocal tumours less than 3 cm and 3 cm or larger. Patient outcomes were also assessed. Results: The mean number of sentinel nodes removed per patient increased from 2.33 in 2000 to 4.17 in 2006. For patients with unifocal tumours less than 3 cm, 47 of 147 (32.0%) were sentinel node positive compared with 15 of 30 (50%) for multifocal tumours less than 3 cm (P = 0.04), 19 of 28 (67.9%) for unifocal tumours 3 cm or larger (P < 0.001) and 7 of 8 (87.5%) for multifocal tumours 3 cm or larger (P = 0.003). Following axillary dissection, 20 of 48 (41.7%) patients with sentinel node macrometastases were found to have positive non‐sentinel nodes, compared with 4 of 20 (20.0%) and 1 of 8 (12.5%) for patients with sentinel node micrometastases and isolated tumour cells. The mean total number of positive nodes was 1.74 compared with 4.21 for unifocal tumours less than or greater than 3 cm, respectively (P = 0.004). No axillary recurrences were detected during the follow‐up period. Conclusion: Although patients with large and/or multifocal tumours were more likely to have a positive sentinel node, the findings provide some indication that SNB may be reliable for staging the axilla in these patients. 相似文献
2.
According to tumor‐node‐metastasis classification, tumor size should be based only on the largest tumor for multifocal and multicentric (MFMC) carcinomas. We estimated tumor size of MFMC carcinoma using either largest dimension of the largest tumor (dominant tumor size) or sum of the largest dimension of all tumors (aggregate tumor size), and compared the risk of axillary lymph node metastasis and prognosis between MFMC and unifocal carcinoma. We retrospectively reviewed the file records of 3,616 patients with MFMC (258 patients, 7.1%) and unifocal (3,358 patients) carcinoma. In T1 and T2 tumor subgroups, using dominant (p = 0.001 and p < 0.001) and aggregate (p = 0.017 and p = 0.004) tumor size axilla‐positivity ratio was significantly higher in MFMC carcinoma compared with unifocal carcinoma. In stage I and II disease classified according to either dominant or aggregate tumor size, there was no significant survival difference between MFMC and unifocal carcinoma patients. In patients with stage III disease by dominant and aggregate tumor size disease‐free survival was significantly worse in MFMC carcinoma compared with unifocal carcinoma (p = 0.036 and p = 0.041); multifocality and multicentricity had no independent prognostic significance (p = 0.074 and p = 0.079). The risk of axillary metastasis in MFMC carcinoma was higher than unifocal carcinoma, regardless of the method employed for tumor size estimation. MFMC carcinoma staged according to either dominant or aggregate tumor size had similar survival with unifocal carcinoma. We recommend using the largest dimension of the largest tumor in estimation of tumor size for MFMC carcinoma. 相似文献
3.
Vidya S. Upadhyaya Geok Hoon Lim Eugenie Yi Kar Chan Stephanie M. C. Fook-Chong Lester Chee Hao Leong 《The breast journal》2020,26(2):162-167
We evaluate the preoperative breast cancer (BC) characteristics that affect the diagnostic accuracy of axillary ultrasound (US) and determine the reliability of US in the different subgroups of BC patients. Axillary US assessments in women with invasive BC diagnosed between 2009 and 2016 in a single institution were retrospectively reviewed. The diagnostic accuracy of axillary US was obtained using surgical nodal histology as the gold standard. Preoperative breast tumor sonographic and histological factors affecting axillary US diagnostic accuracy were examined. Of the 605 newly diagnosed invasive BC cases reviewed, 251 (41.5%) had nodal metastases. Axillary US sensitivity was 75.7%, specificity 92.9%, positive predictive value 88.4%, negative predictive value 84.4%, and false‐negative rate 24.3%. Lower US sensitivity was seen with invasive lobular cancer (ILC) (P = .043), grade I/II, (P = .021), unifocal (P = .039), and smaller tumors (P < .001). US specificity was lower in grade III (P < .001), estrogen receptor (ER)‐negative (P < .001), progesterone receptor (PR)‐negative (P = .004), HER2‐positive (P = .015), triple‐negative (P = .001), and larger breast tumors (P < .001). US has moderate sensitivity and good specificity in detecting metastatic axillary lymph nodes. Based on preoperative cancer characteristics, US was less sensitive for nodal metastases from ILC, unifocal, lower grade, and smaller breast tumors. It was also less specific in grade III, ER‐negative, PR‐negative, HER2‐positive, triple‐negative, and larger breast tumors. Caution is suggested in interpreting the US axillary findings of patients with these preoperative tumor features. 相似文献
4.
V. Parmar R. Hawaldar N.S. Nair T. Shet V. Vanmali S. Desai S. Gupta V. Rangrajan I. Mittra R.A. Badwe 《Breast (Edinburgh, Scotland)》2013,22(6):1081-1086
BackgroundSentinel node biopsy (SNB) was initially conceived as excision of the first station axillary lymph node(s) (LN) identified by radioactive and/or blue dye uptake. The definition was subsequently enlarged to also include palpable lymph nodes in the vicinity of sentinel node(s) (SN). We reasoned that the excision of this combination of nodes might be best achieved by sampling the lower axilla.MethodsEach patient underwent low axillary sampling (LAS) and identification of SN in the excised specimen followed by complete axillary lymph node dissection (ALND). LAS was defined as excision of all fibrofatty tissue overlying the second digitation of serratus anterior below the intercostobrachial nerve and was carried out following a pre-operative injection of radioactive colloid and an intra-operative injection of blue dye. Blue and/or hot nodes (B&/HN) in the dissected tissue and remaining axilla, along with any palpable nodes within the sampled tissue, were defined as SN. The primary endpoint of the study was to compare false negative rates (FNR) of SN with that of LAS in predicting axillary LN status (NCT00128362).FindingsThe study was performed between March 2004 and December 2011 in 478 women with clinically node negative axilla. On histopathological evaluation the median tumor size was 2.5 cm and axillary nodal metastases were found in 34.1% of patients. The FNR of SNB (12.7%, 95% CI 8.1–19.4) and LAS (10.5%, 95% CI 6.6–16.2) were not significantly different (p = 0.56). The FNR of B&/HN alone, without palpable nodes, (29.0%, 95% CI 22.5–36.6) was significantly inferior to those of SNB (p = 0.0007) and LAS (p = 0.0003).InterpretationLAS is as accurate as SNB in predicting axillary LN status in women with clinically node negative operable breast cancer. Confining SNB procedure to excision of B&/HN, significantly increases the risk of leaving behind metastatic lymph nodes in the axilla. LAS is an effective and low cost procedure that minimizes axillary surgery and can be implemented widely.Registry Name: Clinicaltrials.gov.Registration Number: NCT00128362. 相似文献
5.
BACKGROUND: Sentinel node biopsy (SNB) is a standard staging procedure in early breast cancer. Its suitability for larger tumours has been questioned. This study evaluated the reliability of SNB in women with invasive breast cancer larger than 3 cm in diameter who were clinically axillary node negative. METHODS: Some 109 women with a tumour larger than 3 cm on pathological analysis were identified from the Swedish prospective SNB database. They were included if a completion axillary clearance was planned, regardless of SNB results. RESULTS: The sentinel node detection rate was 103 (94.5 per cent) of 109. The overall false-negative rate was eight (13 per cent) of 64. Although a preoperative diagnosis of multifocal tumour was an exclusion criterion, 16 such cases were revealed on postoperative pathological examination. The false-negative rate in this subgroup was higher than that in women with a unifocal tumour (four (31 per cent) of 13 versus four (8 per cent) of 51; P = 0.012). No other significant predictors of a false-negative sentinel node biopsy were identified. CONCLUSION: SNB is feasible in patients with unifocal breast tumours larger than 3 cm. When large tumour size coincides with multifocality, however, the false-negative rate seems to be increased and a completion axillary clearance should be considered even if the SNB is negative. 相似文献
6.
Nicole E. Sharp MD FACS Darren B. Sachs DO Nicole M. Melchior DO Philip Albaneze MD FACS Salvatore Nardello DO Elin R. Sigurdson MD PhD FACS Mengying Deng MMath Allison A. Aggon DO FACOS John M. Daly MD FACS Richard J. Bleicher MD FACS 《The breast journal》2021,27(4):335-344
Prospective trials demonstrate that sentinel node (SN) biopsy after neo-adjuvant chemotherapy (NACT) has a significant false-negative rate (FNR) when only 1 or 2 SNs are removed. It is unknown whether this increased FNR correlates with an elevated risk of recurrence. Tumor Registry data at an NCI-Designated Comprehensive Cancer Center were reviewed from 2004 to 2018 for patients having a negative SN biopsy after NACT. Among 190 patients with histologically negative nodes after NACT having 1 (n = 42), 2 (n = 46), and ≥3 (n = 102) SNs, axillary recurrences occurred in 7.14%, 0%, and 1.96% (p = 0.09), breast recurrences occurred in 2.38%, 6.52%, and 0.98% (p = 0.12), and distance recurrences occurred in 16.67%, 8.70%, and 7.84% (p = 0.27), respectively. Time to first recurrence did not differ by SN count (p = 0.41). After adjustment for age, race, clinical stage, and receptor status, there were no differences in the rates of axillary (p = 0.26), breast (p = 0.44), or distance recurrence (p = 0.24) by numbers of SNs harvested. Median follow-up was 46.8 months. Despite higher post-NACT FNRs reported in randomized trials for patients having <3 sentinel nodes, recurrence rates were not significantly different for 1 versus 2 versus ≥3 SNs. This suggests that patients having 1 or 2 post-NACT SNs identified may not necessitate axillary dissection. 相似文献
7.
Multifocal and Multicentric Breast Cancer is Associated with Increased Local Recurrence Regardless of Surgery Type
下载免费PDF全文
![点击此处可从《The breast journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Talha Shaikh MD Tiffany Y. Tam MD Tianyu Li MS Shelly B. Hayes MD Lori Goldstein MD Richard Bleicher MD Marcia Boraas MD Elin Sigurdson MD Paula D. Ryan MD PhD Penny Anderson MD 《The breast journal》2015,21(2):121-126
Multifocal and multicentric breast cancers have been correlated with poor prognostic factors and worse outcomes versus unifocal disease. We evaluated the impact of multifocal and multicentric disease versus case controls with unifocal disease, matching for age, grade, T‐, and N‐stage. A total of 110 patients with multifocal (n = 93) or multicentric (n = 17) disease and 263 matched case controls were identified with a median follow‐up of 53 months and 64 months, respectively. The actuarial local control rates for the multifocal/multicentric and unifocal group were 88% and 97%, respectively at both 5 and 10 years (p < 0.001). On multivariate analysis, multifocal/multicentric disease remained associated with higher local recurrence after controlling for other covariates including surgery type. The disease‐free survival rates in the multifocal/multicentric group at 5 and 10 years were 75% and 71%, respectively, versus 87% and 78% at 10 years (p = 0.01). On multivariate analysis, multifocal/multicentric disease was no longer associated with worse disease‐free survival. There was no difference in the cohorts in terms of regional control, overall survival, or cancer specific survival. Our findings suggest that multifocal/multicentric disease may be associated with worse outcomes versus unifocal disease regardless of type of surgery. This suggests a more biologically aggressive cancer and may be an important consideration when managing these patients. Further studies are needed to better understand the impact of multifocal/multicentric breast cancers on outcomes. 相似文献
8.
Surgical Resection Versus Radiofrequency Ablation in the Treatment of Small Unifocal Hepatocellular Carcinoma 总被引:1,自引:0,他引:1
M. Abu-Hilal J. N. Primrose A. Casaril M. J. W. McPhail N. W. Pearce N. Nicoli 《Journal of gastrointestinal surgery》2008,12(9):1521-1526
Background Hepatocellular carcinoma (HCC) has a high worldwide prevalence and mortality. While surgical resection and transplantation
offers curative potential, donor availability and patient liver status and comorbidities may disallow either. Interventional
radiological techniques such as radiofrequency ablation (RFA) may offer acceptable overall and disease-free survival rates.
Materials and Methods Sixty-eight cirrhotic patients matched for age, sex, tumor size, and Child–Pugh grade with small (1–5 cm) unifocal HCC were
studied retrospectively to find determinants of overall and disease-free survival in those treated with surgical resection
and RFA between 1991 and 2003.
Results Multivariate analysis using Cox proportional regression modeling showed that overall survival was related to tumor recurrence
(p = 0.010), tumor diameter (p = 0.002), and treatment modality (p = 0.014); overall p = 0.008. Recurrence was independently related to the use of RFA over surgery (p = 0.023) on multivariate analysis; overall p = 0.034.
Conclusion Surgical resection offers longer disease-free survival and potentially longer overall survival than RFA in patients with small
unifocal HCC. 相似文献
9.
Brian R. Untch MD Frank L. Palmer BA Ian Ganly MD Snehal G. Patel MD R. Michael Tuttle MD Jatin P. Shah MD Ashok A. Shaha MD 《Annals of surgical oncology》2014,21(4):1374-1378
Background
At our institution, thyroid lobectomy is employed as a definitive operation for unifocal intrathyroidal low risk cancers and thus completion thyroidectomy is rarely performed. The purpose of this study was to identify the indications for selective completion thyroidectomy and to report oncologic outcomes.Methods
A retrospective review was performed to identify patients who underwent planned completion thyroidectomy for well-differentiated thyroid carcinoma (WDTC) from 2001 to 2010 based on initial lobectomy pathology. Assessment for risk of recurrence was based on the American Thyroid Association Initial Risk Stratification.Results
During the 10-year study period, 79 patients underwent completion thyroidectomy for WDTC. Forty-four (56 %) patients were low risk and 35 (44 %) were intermediate risk. Completion thyroidectomy was recommended for 64 patients, whereas 15 patients were given an option of surveillance but ultimately decided to have surgery. Patients in the “recommended group” had more T3 tumors and fewer T1a tumors (p = 0.005 and 0.006, respectively). These patients also were more likely to be intermediate risk (p = 0.008) and to present with aggressive histology (p = 0.002). The rate of contralateral tumors (n = 27) was similar between both groups (35 and 33 %, respectively). Contralateral cancers were micropapillary in 24 of 27 (89 %) patients, 10 (40 %) of whom had multifocal disease. There were two pulmonary recurrences and no local-regional recurrences (median follow-up of 42.3 months).Conclusions
Completion thyroidectomy is infrequent and performed for a select group of intermediate and low risk WDTCs at our institution with low recurrence rates. Incidental multifocal and unifocal contralateral cancers are common after completion thyroidectomy. 相似文献10.
Background In sporadic and hereditary medullary thyroid cancer, tumor multifocality may constitute an independent risk factor of lymph
node metastasis on top of primary tumor size when the diameter of the largest primary tumor is the same.
Methods Included in this institutional cohort study were 232 consecutive patients operated on at our institution for hitherto untreated
medullary thyroid cancer. Associations of clinicopathologic variables with lymph node metastasis were investigated simultaneously
using multivariate Cox regression analysis.
Results On univariate analysis, multifocal cancers developed lymph node metastases significantly more often (p ≤ 0.005) than unifocal cancers, in both the sporadic (90% vs. 41%) and the hereditary setting (48% vs. 14%). On multivariate
Cox regression analysis on lymph node metastasis as a function of primary tumor diameter, only multifocal (vs. unifocal) tumor
growth was significantly associated with lymph node metastasis (odds ratio [OR] = 2.5; p = 0.01). When multifocal growth was removed as an independent variable from the Cox model, heredity became the only significant
predictor (OR = 3.1; p < 0.0001).
Conclusion The excess risk of lymph node metastasis of 34%-49% in multifocal medullary thyroid cancer seems to be caused by concurrent
smaller thyroid cancers. A diagnosis of more than one medullary thyroid cancer signifies a higher risk of lymph node metastasis,
warranting systematic lymph node dissection. 相似文献
11.
A. García Fernández C. Chabrera M. García Font M. Fraile J.M. Lain I. Barco C. González S. Gónzalez A. Reñe E. Veloso J. Cassadó A. Pessarrodona N. Giménez 《Breast (Edinburgh, Scotland)》2013,22(5):902-907
Sentinel Node Biopsy (SNB) is a minimally invasive alternative to elective axillary lymph node dissection (ALND) for nodal staging in early breast cancer. The present study was conducted to evaluate prognostic implications of a negative sentinel node (SN) versus a positive SN (followed by completion ALND) in a closely followed-up sample of early breast cancer patients.We studied 889 consecutive breast cancer patients operated for 908 primaries. Patients received adjuvant therapy with chemotherapy, hormone therapy and eventually trastuzumab. Radiation therapy was based on tangential radiation fields that usually included axillary level I.Median follow-up was 47 months. Axillary recurrence was seen in 1.2% (2/162) of positive SN patients, and 0.8% (5/625) of negative SN patients (p = n.s.). There was an overall 3.2% loco-regional failure rate (29/908). Incidence of distant recurrence was 3.3% (23/693) for negative SN patients, and 4.6% (9/196) for positive SN patients (p = n.s.). Overall mortality rate was 4% (8/198) for positive SN patients, while the corresponding specific mortality rate was 2.5% (5/198). For patients with negative SNs, overall mortality was 4.9% (34/693), and the specific mortality was 1.4% (19/693) (p = n.s.).We did not find significant differences in axillary/loco-regional relapse, distant metastases, disease-free interval or mortality between SN negative and SN positive patients, with a follow-up over 4 years. 相似文献
12.
Alessandro Testori MD Gian Luca De Salvo MD Maria Cristina Montesco MD Giuseppe Trifirò MD Simone Mocellin MD PhD Giorgio Landi MD Giuseppe Macripò MD Paolo Carcoforo MD Giuseppe Ricotti MD Giuseppe Giudice MD Franco Picciotto MD Davide Donner MD Franco Di Filippo MD Javier Soteldo MD Dario Casara MD Mauro Schiavon MD Antonella Vecchiato MD Sandro Pasquali MD Federica Baldini MD Giovanni Mazzarol MD Carlo Riccardo Rossi MD 《Annals of surgical oncology》2009,16(7):2018-2027
13.
Jennifer D. Motter Kyle R. Jackson Jane J. Long Madeleine M. Waldram Babak J. Orandi Robert A. Montgomery Mark D. Stegall Stanley C. Jordan Enrico Benedetti Ty B. Dunn Lloyd E. Ratner Sandip Kapur Ronald P. Pelletier John P. Roberts Marc L. Melcher Pooja Singh Debra L. Sudan Marc P. Posner Jose M. El-Amm Ron Shapiro Matthew Cooper Jennifer E. Verbesey George S. Lipkowitz Michael A. Rees Christopher L. Marsh Bashir R. Sankari David A. Gerber Jason R. Wellen Adel Bozorgzadeh A. Osama Gaber Eliot C. Heher Francis L. Weng Arjang Djamali J. Harold Helderman Beatrice P. Concepcion Kenneth L. Brayman Jose Oberholzer Tomasz Kozlowski Karina Covarrubias Allan B. Massie Dorry L. Segev Jacqueline M. Garonzik-Wang 《American journal of transplantation》2021,21(4):1612-1621
Incompatible living donor kidney transplant recipients (ILDKTr) have pre-existing donor-specific antibody (DSA) that, despite desensitization, may persist or reappear with resulting consequences, including delayed graft function (DGF) and acute rejection (AR). To quantify the risk of DGF and AR in ILDKT and downstream effects, we compared 1406 ILDKTr to 17 542 compatible LDKT recipients (CLDKTr) using a 25-center cohort with novel SRTR linkage. We characterized DSA strength as positive Luminex, negative flow crossmatch (PLNF); positive flow, negative cytotoxic crossmatch (PFNC); or positive cytotoxic crossmatch (PCC). DGF occurred in 3.1% of CLDKT, 3.5% of PLNF, 5.7% of PFNC, and 7.6% of PCC recipients, which translated to higher DGF for PCC recipients (aOR = 1.031.682.72). However, the impact of DGF on mortality and DCGF risk was no higher for ILDKT than CLDKT (p interaction > .1). AR developed in 8.4% of CLDKT, 18.2% of PLNF, 21.3% of PFNC, and 21.7% of PCC recipients, which translated to higher AR (aOR PLNF = 1.452.093.02; PFNC = 1.672.403.46; PCC = 1.482.243.37). Although the impact of AR on mortality was no higher for ILDKT than CLDKT (p interaction = .1), its impact on DCGF risk was less consequential for ILDKT (aHR = 1.341.621.95) than CLDKT (aHR = 1.962.292.67) (p interaction = .004). Providers should consider these risks during preoperative counseling, and strategies to mitigate them should be considered. 相似文献
14.
《Breast (Edinburgh, Scotland)》2014,23(3):234-243
The Androgen Receptor (AR) is a potential prognostic marker and therapeutic target in breast cancer. We evaluated AR protein expression in high-risk breast cancer treated in the adjuvant setting. Tumors were subtyped into luminal (ER+/PgR±/AR±), molecular apocrine (MAC, [ER−/PgR−/AR+]) and hormone receptor negative carcinomas (HR-negative, [ER−/PgR−/AR−]). Subtyping was evaluated with respect to prognosis and to taxane therapy. High histologic grade (p < 0.001) and increased proliferation (p = 0.001) more often appeared in MAC and HR-negative than in luminal tumors. Patients with MAC had outcome comparable to the luminal group, while patients with HR-negative disease had increased risk for relapse and death. MAC outcome was favorable upon taxane-containing treatment; this remained significant upon multivariate analysis for overall survival (HR 0.31, 95%CI 0.13–0.74, interaction p = 0.035) and as a trend for time to relapse (p = 0.15). In conclusion, AR-related subtyping of breast cancer may be prognostic and serve for selecting optimal treatment combinations. 相似文献
15.
目的:探讨多灶性甲状腺微小乳头状癌(PTMC)临床病理特征及预防性中央区淋巴结清扫的意义。方法:回顾湘雅医院甲状腺外科2013年7月—2016年12月收治的270例PTMC患者资料,比较多灶PTMC与单灶性PTMC患者临床病理因素的差异,并分析多灶性PTMC中央区淋巴结转移的危险因素。结果:270例患者中共120例多灶性PTMC(44.4%)。与单灶性PTMC患者比较,多灶性PTMC患者男性比例增加、中央区淋巴结转移与包膜侵犯发生率明显升高(均P0.05)。多灶PTMC患者的肿瘤最大直径(5~10mmvs.5mm)及是否存在包膜侵犯与中央区淋巴结转移发生率有关(均P0.05),而病灶的数目(2vs.≥3)及分布(单侧vs.双侧)与中央区淋巴结的转移发生率无关(均P0.05)。结论:多灶性PTMC较单灶PTMC具有较差的临床病理特征,中央区淋巴结转移风险增加。多灶性PTMC行预防性中央区淋巴结清扫是很有必要的,尤其对于是肿瘤较大、有包膜侵犯的患者。 相似文献
16.
Grantley Gill 《Annals of surgical oncology》2009,16(2):266-275
We sought the extent to which arm morbidity could be reduced by using sentinel-lymph-node-based management in women with clinically
node-negative early breast cancer. One thousand eighty-eight women were randomly allocated to sentinel-lymph-node biopsy followed
by axillary clearance if the sentinel node was positive or not detected (SNBM) or routine axillary clearance (RAC, sentinel-lymph-node
biopsy followed immediately by axillary clearance). Sentinel nodes were located using blue dye, alone or with technetium-labeled
antimony sulfide colloid. The primary endpoint was increase in arm volume from baseline to the average of measurements at
6 and 12 months. Secondary endpoints were the proportions of women with at least 15% increase in arm volume or early axillary
morbidity, and average scores for arm symptoms, dysfunctions, and disabilities assessed at 6 and 12 months by patients with
the SNAC Study-Specific Scales and other quality-of-life instruments. Sensitivity, false-negative rates, and negative predictive
values for sentinel-lymph-node biopsy were estimated in the RAC group. The average increase in arm volume was 2.8% in the
SNBM group and 4.2% in the RAC group (P = 0.002). Patients in the SNBM group gave lower ratings for arm swelling (P < 0.001), symptoms (P < 0.001), and dysfunctions (P = 0.02), but not disabilities (P = 0.5). Sentinel nodes were found in 95% of the SNBM group (29% positive) and 93% of the RAC group (25% positive). SNB had
sensitivity 94.5%, false-negative rate 5.5%, and negative predictive value 98%. SNBM was successfully undertaken in a wide
range of surgical centers and caused significantly less morbidity than RAC.
A full list of contributors is provided in the Appendix. 相似文献
17.
E. N. Pijnappel N. Bhoo-Pathy J. Suniza M. H. See G. H. Tan C. H. Yip M. Hartman N. A. Taib H. M. Verkooijen 《World journal of surgery》2014,38(12):3133-3137
Background
In settings with limited resources, sentinel lymph node biopsy (SNB) is only offered to breast cancer patients with small tumors and a low a priori risk of axillary metastases.Objective
We investigated whether CancerMath, a free online prediction tool for axillary lymph node involvement, is able to identify women at low risk of axillary lymph node metastases in Malaysian women with 3–5 cm tumors, with the aim to offer SNB in a targeted, cost-effective way.Methods
Women with non-metastatic breast cancers, measuring 3–5 cm were identified within the University Malaya Medical Centre (UMMC) breast cancer registry. We compared CancerMath-predicted probabilities of lymph node involvement between women with versus without lymph node metastases. The discriminative performance of CancerMath was tested using receiver operating characteristic (ROC) analysis.Results
Out of 1,017 patients, 520 (51 %) had axillary involvement. Tumors of women with axillary involvement were more often estrogen-receptor positive, progesterone-receptor positive, and human epidermal growth factor receptor (HER)-2 positive. The mean CancerMath score was higher in women with axillary involvement than in those without (53.5 vs. 51.3, p = 0.001). In terms of discrimination, CancerMath performed poorly, with an area under the ROC curve of 0.553 (95 % confidence interval CI 0.518–0.588). Attempts to optimize the CancerMath model by adding ethnicity and HER2 to the model did not improve discriminatory performance.Conclusion
For Malaysian women with tumors measuring 3–5 cm, CancerMath is unable to accurately predict lymph node involvement and is therefore not helpful in the identification of women at low risk of node-positive disease who could benefit from SNB. 相似文献18.
Swapnil D. Kachare MD MBA Jan H. Wong MD Nasreen A. Vohra MD Emmanuel E. Zervos MD Timothy L. Fitzgerald MD 《Annals of surgical oncology》2014,21(5):1624-1630
Background
Although sentinel lymph node biopsy (SNB) has become a standard for Merkel cell carcinoma (MCC), the impact on survival is unclear. To better define the staging and therapeutic value of SNB, we compared SNB with nodal observation.Methods
Patients with clinical stage I and II MCC in the Surveillance, Epidemiology, and End Results (SEER) registry undergoing surgery between 2003 and 2009 were identified and divided into two groups—SNB and observation.Results
A total of 1,193 patients met the inclusion criteria (SNB 474 and Observation 719). The median age was 78 years, and the majority were White (95.3 %), male (58.8 %), received radiation therapy (52.9 %) and had T1 tumors (65.3 %). Twenty-four percent had a positive SNB. SNB patients were younger (73 vs. 81 years; p < 0.0001), had T1 tumors (69.6 vs. 62.5 %; p = 0.04) and received radiotherapy (57.8 vs. 40 %; p < 0.0001). Among biopsy patients, a negative SNB was associated with improved 5-year MCC-specific survival (84.5 vs. 64.6 %; p < 0.0001). Univariate analysis demonstrated an increased 5-year MCC-specific survival for the SNB group versus the Observation group (79.2 vs. 73.8 %; p = 0.004), female gender (83.2 vs. 70.4 %; p = 0.0004), and lower T stage (p < 0.0001). On Cox regression, diminished survival was noted for the Observation group (risk ratio [RR] 1.43; p = 0.04), male gender (RR 2.06; p < 0.0001), and a higher T stage.Conclusion
SNB for MCC provides prognostic information and is associated with a significant survival advantage. 相似文献19.
Predictors of Surgical Margin Status in Breast-Conserving Surgery Within a Breast Screening Program 总被引:1,自引:1,他引:0
Kurniawan ED Wong MH Windle I Rose A Mou A Buchanan M Collins JP Miller JA Gruen RL Mann GB 《Annals of surgical oncology》2008,15(9):2542-2549
Background Breast-conserving surgery (BCS) requires clear surgical margins to minimize local recurrence. We sought to identify groups
of patients at higher risk of involved margins who might benefit from preoperative counselling and/or more generous excision
at the first operation.
Methods We reviewed demographic, clinical, radiological and pathological records of all women diagnosed with ductal carcinoma in situ
(DCIS) or invasive cancer (IC) through a population-based breast screening program in Melbourne, Australia between 1994 and
2005.
Results A total of 2,160 women were diagnosed with DCIS or IC. We excluded 199 who had mastectomy (TM) as initial procedure or had
missing data. Three hundred and thirteen had a diagnostic biopsy. Of 1,648 women who had BCS after a preoperative diagnosis
of DCIS or IC, 13.5% had involved margins, 16.6% had close (≤1 mm), and 69.8% clear (>1 mm) margins. Of the patients, 281/1,648
(17.1%) underwent re-excision, of whom 93 (33.1%) had residual disease identified. Mammographic microcalcifications (P < 0.0001), absence of a mammographic mass (P = 0.002), presence of DCIS (P < 0.0001), high tumour grade (P < 0.0001), large size (P < 0.0001), multifocal disease (P < 0.0001) and lobular histology (P = 0.005) were associated with involved margins. Microcalcifications (odds ratio [OR] 1.97), large size (OR 4.22) and multifocal
disease (OR 2.85) were independently associated with involved margins. Residual disease was associated with involved margins
(P < 0.0001), presence of DCIS (P = 0.05) and large tumour size (P = 0.01).
Conclusion After BCS, patients with mammographic microcalcifications, larger tumour size and multifocal tumours are more likely to have
involved margins. Patients with involved margins, large tumour size and/or a DCIS component are more likely to have residual
disease on re-excision. 相似文献
20.
《Asian journal of surgery / Asian Surgical Association》2021,44(9):1143-1150
The efficacy of anatomical resection (AR) and non-anatomical resection (NR) in the treatment of hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI) remains unknown. This study compared the safety and outcomes of these surgical procedures. A systematic literature search was conducted. The main outcomes were overall survival (OS), disease-free survival (DFS). Overall hazard ratio (HR) was calculated from Kaplan–Meier plots and outcomes using random-effects models. There was no significant difference in postoperative complications between the AR and NR groups (risk ratio [RR]: 0.92, 95% confidence interval [CI]: 0.72–1.17, p = 0.496). OS was higher with AR at 1 year (RR: 0.66, 95% CI: 0.45–0.98, p = 0.037), 3 years (RR: 0.64, 95% CI: 0.50–0.82, p = 0.000), and 5 years (RR: 0.76, 95% CI: 0.65–0.89, p = 0.001). AR was associated with a higher OS rate (HR: 0.62, 95% CI: 0.47–0.82, p = 0.001). AR was associated with improved DFS at 1 year (RR: 0.65, 95% CI: 0.52 to 0.82, p = 0.000), 3 years (RR: 0.75, 95% CI: 0.66 to 0.86, p = 0.000), and 5 years (95% CI: 0.75 to 0.94, p = 0.002). Compared with NR, AR had significant advantages on overall HR of DFS (HR: 0.64, 95% CI: 0.45 to 0.91, p = 0.012). In conclusion, AR was associated with higher rates of OS and DFS in HCC patients with MVI. Thus, for well-presented liver function HCC patients which are predicted to have positive MVI, AR is recommended. 相似文献